首页/数据集/Medicines indicated as unavailable and/or unaffordable in the open comment question.

Medicines indicated as unavailable and/or unaffordable in the open comment question.

NIAID Data Ecosystem2026-05-01 收录

数据链接：

https://figshare.com/articles/dataset/Medicines_indicated_as_unavailable_and_or_unaffordable_in_the_open_comment_question_/23595805 数据链接链接失效反馈

官方服务：

资源简介：

Medicines indicated as unavailable and/or unaffordable in the open comment question.

应用场景：

创建时间：

2023-06-28

相关数据集

Additional file 1.xlsx

疾病靶点发现

药物可及性评估

This study aims to establish a foundation for the precise prevention and treatment of GD by identifying potential therapeutic targets among plasma proteins . Initially, to systematically screen for pr

DataCite Commons2024-11-13 更新70

Access to and price trends of antidiabetic, antihypertensive, and antilipidemic drugs in outpatient settings of the Universal Coverage Scheme in Thailand

药物可及性评估

药品价格趋势分析

Under the Universal Coverage Scheme (UCS) with payment per capita for outpatient (OP) services, hospitals’ financial risks will rise if access to essential drugs increases. This study examined trends

NIAID Data Ecosystem40

Structure-Based Druggability Assessment of the Mammalian Structural Proteome with Inclusion of Light Protein Flexibility

药物可及性评估

隐式口袋识别

Advances reported over the last few years and the increasing availability of protein crystal structure data have greatly improved structure-based druggability approaches. However, in practice, nearly

NIAID Data Ecosystem40

A survey of barriers and facilitators to caffeine use for apnoea of prematurity in low- and middle-income countries

新生儿呼吸暂停

药物可及性评估

Despite its associated benefits which include better long-term pulmonary and neurodevelopmental outcome, the use of caffeine for apnoea of prematurity (AoP) has been limited in low- and middle-income

Taylor & Francis Group2023-08-24 更新60

Development of a Rule-Based Method for the Assessment of Protein Druggability

药物可及性评估

蛋白质结合口袋

Target selection is a critical step in the majority of modern drug discovery programs. The viability of a drug target depends on two components: biological relevance and chemical tractability. The con

NIAID Data Ecosystem40